Device Week, Dec. 7, 2018 - FDA Panel Looks At Heart Failure, Hypertension
On this week's podcast, David Filmore talks with Elizabeth Orr and Reed Miller about the recent meeting of the US FDA Circulatory System Devices Panel, where agency advisors addressed a "Breakthrough" heart failure device and discussed the clinical-trial needs for hypertension devices.
You may also be interested in...
Medtronic’s MiniMed 600 series of insulin pumps is the subject of a high-risk class I recall because a component may break, leading to over- or under-dosing of insulin. The company warned patients of the issue last November.
The US agency made few changes in finalizing a 13 February guidance document on medical devices made to remove plaque from diseased arteries, but did incorporate manufacturer recommendations on corrosion testing and predicate comparisons.
Digital Surgery, a London-based developer of surgical artificial intelligence, analytics, digital education and training solutions, will join Medtronic’s surgical robotics business within its minimally invasive therapies group.